Ancil Pharma Private Limited
About Ancil Pharma Private Limited
Data last updated:
Ancil Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 04 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51397GJ2019PTC111192. Its GSTIN is 24AATCA0113G1Z3 (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yogeshkumar Shermal Maloo and Jashvantkumar Chunilal Patel.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 311 3rd/F Block – B 3876 Tps – 3 Sp – 1 Fp – 100 Lilamani Tower Cen Litho Dudheshwar Road, Ahmedabad, Gujarat, India – 380004.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.57 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹52.32 Lakh (net margin 4.9%) and EBITDA of ₹72.33 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 201% over three years and 138% over five years.
As per MCA filings, the company has open charges of ₹3 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address311 3rd/F Block – B 3876 Tps – 3 Sp – 1 Fp – 100 Lilamani Tower Cen Litho Dudheshwar Road, Ahmedabad, Gujarat, India – 380004
- IndustryHealthcare, Medical & Laboratory Equipment
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ancil Pharma Private Limited
The main business activity of Ancil Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ancil Pharma Private Limited FY 2025 filings available
Ancil Pharma Private Limited reported revenue of ₹10.57 Cr (up 1342% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ancil Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 138% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ancil Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹72.33 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹52.32 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ancil Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ancil Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ancil Pharma Private Limited
Ancil Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mahamantra Industries Private Limited | ₹10.58 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Sachin, Gujarat, India |
| Esbee Exim Pvt Ltd | ₹10.58 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Kolkata, West Bengal, India |
| Kalpatech Engineers & Industries Limited | ₹10.58 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Nashik, Maharashtra, India |
| Bahety Overseas Private Limited | ₹10.57 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Delhi, India |
| S.P. Medicines Private Limited | ₹10.57 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | P O Midnapore, West Bengal, India |
| Ancil Pharma Private Limited this company | ₹10.57 Cr (FY 2025) | •••• | •••• | 1342.0% | •••• | Ahmedabad, Gujarat, India |
| Aj and Sons Private Limited | ₹10.57 Cr (FY 2023) | •••• | •••• | -84.0% | •••• | Thrissur, Kerala, India |
| Omkareshwar Multiservices Private Limited | ₹10.57 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ahmedabad, Gujarat, India |
| Aquaarius Bath Solutions Private Limited | ₹10.57 Cr (FY 2024) | •••• | •••• | 58.0% | •••• | Mumbai, Maharashtra, India |
| Jai Maa Kali Bullion Private Limited | ₹10.57 Cr (FY 2024) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Karoda Online Traders Private Limited | ₹10.57 Cr (FY 2023) | •••• | •••• | 197.0% | •••• | K.K.Nagar, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Ancil Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ancil Pharma Private Limited
Ancil Pharma Private Limited is audited by KIRTI J NAYAK & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KIRTI J NAYAK & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ancil Pharma Private Limited
Ancil Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogeshkumar Shermal Maloo | Director | 04 Dec 2019 | 6 Years 10 Months | Current |
| Jashvantkumar Chunilal Patel | Additional Director | 06 Apr 2022 | 4 Years 6 Months | Current |
| Hareshkumar Kantilal Patel Also directs: Cureill Pharma Private Limited | Additional Director | 04 Apr 2023 | 3 Years 6 Months | Current |
Ownership and Shareholding of Ancil Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ancil Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2025 | Indian Bank | ₹3 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ancil Pharma Private Limited
Employment history and EPFO contributions of people linked to Ancil Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ancil Pharma Private Limited
Ancil Pharma Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Hareshkumar Kantilal Patel was appointed as Additional Director on 04 Apr 2023.
Credit Ratings, Litigation & Regulatory Alerts for Ancil Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ancil Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ancil Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ancil Pharma Private Limited
Ancil Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AATCA0113G1Z3 | Gujarat | Active | 03 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ancil Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ancil Pharma Private Limited
Ancil Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 04 December 2019 (7+ years old) and is registered under CIN U51397GJ2019PTC111192.
Ancil Pharma reported revenue of ₹10.57 Cr for FY 2025 (up 1342% YoY).
Ancil Pharma has 3 current directors:
- Yogeshkumar Shermal Maloo - Director
- Jashvantkumar Chunilal Patel - Additional Director
- Hareshkumar Kantilal Patel - Additional Director
Ancil Pharma reported a net profit of ₹52.32 Lakh (net margin 4.9%) and EBITDA of ₹72.33 Lakh (EBITDA margin 6.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ancil Pharma is 201% over three years and 138% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ancil Pharma is 24AATCA0113G1Z3, registered in Gujarat.
The CIN (Corporate Identification Number) of Ancil Pharma is U51397GJ2019PTC111192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ancil Pharma was incorporated on 04 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Ancil Pharma by revenue are Mahamantra Industries Private Limited, Esbee Exim Pvt Ltd, Kalpatech Engineers & Industries Limited, Bahety Overseas Private Limited, S.P. Medicines Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Hareshkumar Kantilal Patel was appointed as Additional Director on 04 Apr 2023. Amit Govindbhai Shah ceased to be Director on 31 Mar 2023. Jashvantkumar Chunilal Patel was appointed as Additional Director on 06 Apr 2022. Ancil Pharma has 5 board changes on record in total.
The registered office of Ancil Pharma is at 311 3rdF Block – B 3876 Tps – 3 Sp – 1 Fp – 100 Lilamani Tower Cen Litho Dudheshwar Road, Ahmedabad, Gujarat, India – 380004.